Sat.Dec 18, 2021 - Fri.Dec 24, 2021

article thumbnail

The Laboratory community bounces back at Lab Innovations~ A round-up of Lab Innovations 2021 ~

Drug Discovery Today

Lab Innovations, the UK’s largest trade exhibition for the laboratory industry, returned to the NEC, Birmingham, on November 3 and 4, 2021 and brought the laboratory community together for the first time after almost two years apart. With 3,117 visitors, the show gave the industry’s leading professionals and companies the chance to meet face-to-face, network and discover the latest innovations.

article thumbnail

Which pharmaceutical companies have the most drug patents in Czech Republic?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Drug Channels News Roundup, December 2021: CAR-T Profits, UM Boom, Health Plans vs. Experts, Confused Physicians, and Health Insurance Explained

Drug Channels

Happy New Year, everyone! We made it through a challenging 2021. Ring in 2022 with these noisemakers from the Drug Channels party bag: Hospitals earn incredible markups on CAR-T therapies Utilization management booms Health plans often ignore clinical guidelines Benefit designs flummox physicians Plus: an awesomely concise summary of U.S. health insurance.

article thumbnail

The Domain Reform for Unlawful Drug Sellers Act is Big Pharma’s Bill

Policy Prescription

UPDATE : Senator Amy Klobuchar (D-MN) has withdrawn her sponsorship and support for this bill. A new bill introduced by Sens. Mark Rubio (R-FL) and Amy Klobuchar (D-MN) , called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

15th Edition Pharma Resource Planning and Portfolio OptimizationPhiladelphia, PA | Option to attend virtuallyFebruary 22-24, 2022 | 08:30 EDT

Drug Discovery Today

Directing Strategy, Decision Making and Resource Optimization for Optimal Portfolio Success

100
100
article thumbnail

New patent for Amgen Inc drug CORLANOR

Drug Patent Watch

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 89

More Trending

article thumbnail

CDER & CBER Real World Data and Real World Evidence

Pharmaceutical Development Group

Start Up and Generic Pharmaceutical Drug and Biologic Companies have high quality, affordable products that improve the quality of life for their patients. However, this often is associated with austere conditions wherein time and funds are both in short supply. Effective use of Real World Data (RWD) and Real World Evidence (RWE) can reduce costs of Pharmaceutical Drug and Biologic Products and Process Development, Drug Development Services , expedite a FDA Pre-Submission Review, and lead to FDA

article thumbnail

CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery

Drug Discovery Today

Leveraging AI to Accelerate the Path From Diagnosis to Cure

100
100
article thumbnail

New patent for Allergan Holdings drug VIBERZI

Drug Patent Watch

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are sixteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 87
article thumbnail

Which pharmaceutical companies have the most lotion dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…. The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Hong Kong?

Drug Patent Watch

This chart shows the drugs with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

New patent expiration for Pacira Pharms drug EXPAREL

Drug Patent Watch

Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are two…. The post New patent expiration for Pacira Pharms drug EXPAREL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Ferring Pharms drug CLENPIQ

Drug Patent Watch

Annual Drug Patent Expirations for CLENPIQ Clenpiq is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are two…. The post New patent for Ferring Pharms drug CLENPIQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Intra-cellular drug CAPLYTA

Drug Patent Watch

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…. The post New patent for Intra-cellular drug CAPLYTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

New patent for Alkermes Inc drug LYBALVI

Drug Patent Watch

Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…. The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Clarus drug JATENZO

Drug Patent Watch

Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are five patents protecting…. The post New patent for Clarus drug JATENZO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Vanda Pharms drug HETLIOZ LQ

Drug Patent Watch

Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Bayer Hlthcare drug CIPRO XR

Drug Patent Watch

Annual Drug Patent Expirations for CIPRO+XR Cipro Xr is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug. The generic…. The post New patent expiration for Bayer Hlthcare drug CIPRO XR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Which pharmaceutical drugs have the most drug patents in Czech Republic?

Drug Patent Watch

This chart shows the drugs with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

New patent for Amgen Inc drug CORLANOR

Drug Patent Watch

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Which pharmaceutical companies have the most drug patents in Sweden?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

New patent for Abbvie Inc drug MAVYRET

Drug Patent Watch

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for APIL drug FEMTRACE

Drug Patent Watch

Annual Drug Patent Expirations for FEMTRACE Femtrace is a drug marketed by Apil and is included in one NDA. There are three patents protecting this drug. This drug has eleven…. The post New patent expiration for APIL drug FEMTRACE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Janssen Pharms drug SPRAVATO

Drug Patent Watch

Annual Drug Patent Expirations for SPRAVATO Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Janssen Pharms drug SPRAVATO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Bausch drug VANOS

Drug Patent Watch

Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are four patents protecting…. The post New patent expiration for Bausch drug VANOS appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Abbvie Inc drug MAVYRET

Drug Patent Watch

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Abbvie Inc drug RINVOQ

Drug Patent Watch

Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Gilead drug CAYSTON

Drug Patent Watch

Annual Drug Patent Expirations for CAYSTON Cayston is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting…. The post New patent expiration for Gilead drug CAYSTON appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Bayer Hlthcare drug SAFYRAL

Drug Patent Watch

Annual Drug Patent Expirations for SAFYRAL Safyral is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Bayer Hlthcare drug SAFYRAL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Bayer Hlthcare drug BEYAZ

Drug Patent Watch

Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents…. The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Bayer Hlthcare drug YAZ

Drug Patent Watch

Annual Drug Patent Expirations for YAZ Yaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents…. The post New patent expiration for Bayer Hlthcare drug YAZ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Novartis drug VOTRIENT

Drug Patent Watch

Annual Drug Patent Expirations for VOTRIENT Votrient is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…. The post New patent expiration for Novartis drug VOTRIENT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Which pharmaceutical companies have the most liquid dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most liquid dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most liquid dosed drugs…. The post Which pharmaceutical companies have the most liquid dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.